Characterization of glycopeptide-resistant enterococci from a Swiss hospital

被引:55
作者
Liassine, N
Frei, R
Jan, I
Auckenthaler, R
机构
[1] Univ Hosp Geneva, Cent Lab Bacteriol, CH-1211 Geneva 4, Switzerland
[2] Univ Clin, Bacteriol Lab, Basel, Switzerland
关键词
D O I
10.1128/JCM.36.7.1853-1858.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Between August 1994 and September 1996, 28 glycopeptide-resistant enterococci (GRE) were isolated from 8 infected patients and 11 intestinal carriers hospitalized at the University Hospital of Geneva. Identification to the species was made by both phenotypic (API 20 STREP and Rapid ID 32 STREP systems, and Vitek Gram Positive Identification Card) and genotypic methods using a multiplex PCR assay developed also for the determination of the genotype of glycopeptide resistance (vanA, vanB, vanC1, and vanC2-C3 genes), Fifteen isolates were identified as Enterococcus faecium, 8 as E, gallinarum, 4 as E. faecalis, and 1 as E, hirae, All of the phenotypic identification methods failed to differentiate some isolates of E, gallinarum from E, faecium, or,ice versa, Both vanA (n = 18) and vanB (n = 4) glycopeptide resistance genotypes were found. For the first time, the vanB determinant was found in two isolates of E, gallinarum, Two patients were colonized by two different species containing the vanA gene and one by two different species containing the vanB gene. All vanA isolates were highly resistant to both vancomycin and teicoplanin except for three isolates which were susceptible to teicoplanin, Molecular typing by pulsed-field gel electrophoresis showed identical or similar patterns among E, faecium isolates with the vanA gene in five patients for whom the epidemiological link could not be always elucidated. This study emphasizes the necessity of utilizing both phenotypic and genotypic methods to characterize GRE.
引用
收藏
页码:1853 / 1858
页数:6
相关论文
共 34 条
[21]   PLASMID-MEDIATED RESISTANCE TO VANCOMYCIN AND TEICOPLANIN IN ENTEROCOCCUS-FAECIUM [J].
LECLERCQ, R ;
DERLOT, E ;
DUVAL, J ;
COURVALIN, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (03) :157-161
[22]   EMERGENCE OF ENTEROCOCCUS AS A SIGNIFICANT PATHOGEN [J].
MOELLERING, RC .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (06) :1173-1176
[23]   WHAT CAN WE DO ABOUT VANCOMYCIN-RESISTANT ENTEROCOCCI - RESPONSE [J].
MURRAY, BE .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) :1134-1136
[24]   THE LIFE AND TIMES OF THE ENTEROCOCCUS [J].
MURRAY, BE .
CLINICAL MICROBIOLOGY REVIEWS, 1990, 3 (01) :46-65
[25]  
*NAT COMM CLIN LAB, 1997, M100S7 NAT COMM CLIN
[26]  
NAUSCHUETZ WF, 1993, MED MICROBIOL LETT, V2, P102
[27]   ANALYSIS OF GENES ENCODING D-ALANINE D-ALANINE LIGASE-RELATED ENZYMES IN ENTEROCOCCUS-CASSELIFLAVUS AND ENTEROCOCCUS-FLAVESCENS [J].
NAVARRO, F ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (08) :1788-1793
[28]   Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital [J].
Pegues, DA ;
Pegues, CF ;
Hibberd, PL ;
Ford, DS ;
Hooper, DC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (06) :1565-1570
[29]   VanD-type glycopeptide-resistant Enterococcus faecium BM4339 [J].
Perichon, B ;
Reynolds, P ;
Courvalin, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2016-2018
[30]   Emergence of vancomycin resistance in the genus Streptococcus: Characterization of a vanB transferable determinant in Streptococcus bovis [J].
Poyart, C ;
Pierre, C ;
Quesne, G ;
Pron, B ;
Berche, P ;
TrieuCuot, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :24-29